DDX3 DEAD-box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into Nucleocapsids

Haifeng Wang, Seahee Kim, Wang-Shick Ryu

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Viruses utilize host factors in many steps of their life cycles. Yet, little is known about host factors that contribute to the life cycle of hepatitis B virus (HBV), which replicates its genome by reverse transcription. To identify host factors that contribute to viral reverse transcription, we sought to identify cellular proteins that interact with HBV polymerase (Pol) by using affinity purification coupled with mass spectrometry. One of the HBV Pol-interacting host factors identified was DDX3 DEAD-box RNA helicase, which unwinds RNA in an ATPase-dependent manner. Recently, it was shown that DDX3 is essential for both human immunodeficiency virus and hepatitis C virus infection. In contrast, we found that the ectopic expression of DDX3 led to significantly reduced viral DNA synthesis. The DDX3-mediated inhibition of viral DNA synthesis did not affect RNA encapsidation, a step prior to reverse transcription, and indicated that DDX3 inhibits HBV reverse transcription. Mutational analysis revealed that mutant DDX3 with an inactive ATPase motif, but not that with an inactive RNA helicase motif, failed to inhibit viral DNA synthesis. Our interpretation is that DDX3 inhibits viral DNA synthesis at a step following ATP hydrolysis but prior to RNA unwinding. Finally, OptiPrep density gradient analysis revealed that DDX3 was incorporated into nucleocapsids, suggesting that DDX3 inhibits viral reverse transcription following nucleocapsid assembly. Thus, DDX3 represents a novel host restriction factor that limits HBV infection.

Original languageEnglish
Pages (from-to)5815-5824
Number of pages10
JournalJournal of Virology
Volume83
Issue number11
DOIs
Publication statusPublished - 2009 Jun 1

Fingerprint

DEAD-box RNA Helicases
Nucleocapsid
nucleocapsid
reverse transcription
Hepatitis B virus
Reverse Transcription
Viral DNA
synthesis
DNA
RNA
Virus Diseases
Life Cycle Stages
adenosinetriphosphatase
life cycle (organisms)
RNA helicases
RNA Helicases
Nucleotide Motifs
Hepatitis C virus
Human immunodeficiency virus
Hepacivirus

All Science Journal Classification (ASJC) codes

  • Immunology
  • Virology

Cite this

@article{4436dfc10a1249b9924a272891a83388,
title = "DDX3 DEAD-box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into Nucleocapsids",
abstract = "Viruses utilize host factors in many steps of their life cycles. Yet, little is known about host factors that contribute to the life cycle of hepatitis B virus (HBV), which replicates its genome by reverse transcription. To identify host factors that contribute to viral reverse transcription, we sought to identify cellular proteins that interact with HBV polymerase (Pol) by using affinity purification coupled with mass spectrometry. One of the HBV Pol-interacting host factors identified was DDX3 DEAD-box RNA helicase, which unwinds RNA in an ATPase-dependent manner. Recently, it was shown that DDX3 is essential for both human immunodeficiency virus and hepatitis C virus infection. In contrast, we found that the ectopic expression of DDX3 led to significantly reduced viral DNA synthesis. The DDX3-mediated inhibition of viral DNA synthesis did not affect RNA encapsidation, a step prior to reverse transcription, and indicated that DDX3 inhibits HBV reverse transcription. Mutational analysis revealed that mutant DDX3 with an inactive ATPase motif, but not that with an inactive RNA helicase motif, failed to inhibit viral DNA synthesis. Our interpretation is that DDX3 inhibits viral DNA synthesis at a step following ATP hydrolysis but prior to RNA unwinding. Finally, OptiPrep density gradient analysis revealed that DDX3 was incorporated into nucleocapsids, suggesting that DDX3 inhibits viral reverse transcription following nucleocapsid assembly. Thus, DDX3 represents a novel host restriction factor that limits HBV infection.",
author = "Haifeng Wang and Seahee Kim and Wang-Shick Ryu",
year = "2009",
month = "6",
day = "1",
doi = "10.1128/JVI.00011-09",
language = "English",
volume = "83",
pages = "5815--5824",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "11",

}

DDX3 DEAD-box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into Nucleocapsids. / Wang, Haifeng; Kim, Seahee; Ryu, Wang-Shick.

In: Journal of Virology, Vol. 83, No. 11, 01.06.2009, p. 5815-5824.

Research output: Contribution to journalArticle

TY - JOUR

T1 - DDX3 DEAD-box RNA helicase inhibits hepatitis B virus reverse transcription by incorporation into Nucleocapsids

AU - Wang, Haifeng

AU - Kim, Seahee

AU - Ryu, Wang-Shick

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Viruses utilize host factors in many steps of their life cycles. Yet, little is known about host factors that contribute to the life cycle of hepatitis B virus (HBV), which replicates its genome by reverse transcription. To identify host factors that contribute to viral reverse transcription, we sought to identify cellular proteins that interact with HBV polymerase (Pol) by using affinity purification coupled with mass spectrometry. One of the HBV Pol-interacting host factors identified was DDX3 DEAD-box RNA helicase, which unwinds RNA in an ATPase-dependent manner. Recently, it was shown that DDX3 is essential for both human immunodeficiency virus and hepatitis C virus infection. In contrast, we found that the ectopic expression of DDX3 led to significantly reduced viral DNA synthesis. The DDX3-mediated inhibition of viral DNA synthesis did not affect RNA encapsidation, a step prior to reverse transcription, and indicated that DDX3 inhibits HBV reverse transcription. Mutational analysis revealed that mutant DDX3 with an inactive ATPase motif, but not that with an inactive RNA helicase motif, failed to inhibit viral DNA synthesis. Our interpretation is that DDX3 inhibits viral DNA synthesis at a step following ATP hydrolysis but prior to RNA unwinding. Finally, OptiPrep density gradient analysis revealed that DDX3 was incorporated into nucleocapsids, suggesting that DDX3 inhibits viral reverse transcription following nucleocapsid assembly. Thus, DDX3 represents a novel host restriction factor that limits HBV infection.

AB - Viruses utilize host factors in many steps of their life cycles. Yet, little is known about host factors that contribute to the life cycle of hepatitis B virus (HBV), which replicates its genome by reverse transcription. To identify host factors that contribute to viral reverse transcription, we sought to identify cellular proteins that interact with HBV polymerase (Pol) by using affinity purification coupled with mass spectrometry. One of the HBV Pol-interacting host factors identified was DDX3 DEAD-box RNA helicase, which unwinds RNA in an ATPase-dependent manner. Recently, it was shown that DDX3 is essential for both human immunodeficiency virus and hepatitis C virus infection. In contrast, we found that the ectopic expression of DDX3 led to significantly reduced viral DNA synthesis. The DDX3-mediated inhibition of viral DNA synthesis did not affect RNA encapsidation, a step prior to reverse transcription, and indicated that DDX3 inhibits HBV reverse transcription. Mutational analysis revealed that mutant DDX3 with an inactive ATPase motif, but not that with an inactive RNA helicase motif, failed to inhibit viral DNA synthesis. Our interpretation is that DDX3 inhibits viral DNA synthesis at a step following ATP hydrolysis but prior to RNA unwinding. Finally, OptiPrep density gradient analysis revealed that DDX3 was incorporated into nucleocapsids, suggesting that DDX3 inhibits viral reverse transcription following nucleocapsid assembly. Thus, DDX3 represents a novel host restriction factor that limits HBV infection.

UR - http://www.scopus.com/inward/record.url?scp=66149138064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=66149138064&partnerID=8YFLogxK

U2 - 10.1128/JVI.00011-09

DO - 10.1128/JVI.00011-09

M3 - Article

VL - 83

SP - 5815

EP - 5824

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 11

ER -